Thalassemia R&D Pipeline Analysis Report, H2-2018
Thalassemia Drug Development Pipeline Study is the latest publication from VPA Research with comprehensive information of Thalassemia pipeline products.
The Thalassemia pipeline guide presents complete overview of drugs currently being developed for Thalassemia. The pipeline review provides insights into different therapeutic candidates in preclinical, research, discovery, NDA/IND, pre registration, phase 1, phase 2, and phase 3 trials).
Drug development phase, current stage, mechanism of action, route of administration, orphan drug/ fast track/ other designations, drug class are provided for each of the Thalassemia pipeline candidate.
Research and Development progress along with latest news related to each of the Thalassemia pipeline candidates is included.
The Thalassemia pipeline guide presents complete overview of drugs currently being developed for Thalassemia. The pipeline review provides insights into different therapeutic candidates in preclinical, research, discovery, NDA/IND, pre registration, phase 1, phase 2, and phase 3 trials).
Drug development phase, current stage, mechanism of action, route of administration, orphan drug/ fast track/ other designations, drug class are provided for each of the Thalassemia pipeline candidate.
Research and Development progress along with latest news related to each of the Thalassemia pipeline candidates is included.
- Major companies participating in therapeutic development of Thalassemia are included in this pipeline report. Company wise pre clinical and clinical products along with details of drug originator, co developers/ licensors are provided.
- Amid strong interest for cure of Thalassemia from companies and institutes, the current research work serves as a reliable and comprehensive source of information of global Thalassemia clinical and pre clinical products.
- The report assists in identifying potential upcoming companies and drugs in Thalassemia pipeline market along with progress of each drug. It also enables users to formulate effective strategies to stay ahead of competition.
- Information in the report is sourced from our proprietary platform, built through extensive primary and secondary research methodology. Data is presented in user friendly and ready to use format.
- Panorama of Thalassemia pipeline markets including statistics on therapeutic drugs and companies involved
- Thalassemia Pipeline candidates across various development phases including both pre clinical, discovery and clinical stages are covered
- Thalassemia pipeline candidates across various ‘Mechanism of Actions’ are also presented in the study
- Overview of companies participating in Thalassemia pipeline with short introduction to their businesses and pipeline projects
- For each pipeline candidate, drug overview, details of mechanism of Action (MOA), originator, co developer and licensee are provided.
- Research and Development progress and trial details, results wherever available, are also included in the pipeline study
- The pipeline study provides information on all ongoing and active projects and also presents the recent news associated with Thalassemia pipeline therapeutics
- Get clear understanding of the entire Thalassemia pipeline, with details on active projects
- Get in detail information of each product with updated information on each project along with key milestones
- Know the list of companies participating in global Thalassemia pipeline along with progress of each of the company’s products and information on associations/collaborations/licensing data
- Get trial information for each pipeline product under development
- Understand the pipeline structure in terms of mechanism of Action, phase and company
I. KEY FINDINGS
1. Companies Investing in Thalassemia Pipeline include
Number of Companies with Thalassemia projects in pre clinical Development
Number of Companies with Thalassemia projects in Clinical Development
Thalassemia Pipeline Companies based in Americas
Thalassemia Pipeline Companies based in Europe
Thalassemia Pipeline Companies based in Asia Pacific
Thalassemia Pipeline Companies based in Rest of the World
2. Pipeline Candidates include
Thalassemia Pipeline Agents in pre clinical/Discovery stage of Development
Thalassemia Pipeline Agents in Clinical Development stage
Thalassemia Pipeline Therapeutic Compounds received special status
Mechanism of Action of most pipeline Drugs
Small molecules among the Thalassemia Pipeline agents
II. INSIGHTS INTO THALASSEMIA PIPELINE
1. Disease Overview
Introduction to Thalassemia
Symptoms and Causes of Thalassemia
Treatment or Prevention Options for Thalassemia
Other Details
2. Phase wise Pipeline Compounds
Thalassemia Pipeline Pre Clinical/Discovery stage Drugs
Thalassemia Pipeline Phase 1 stage Drugs
Thalassemia Pipeline Phase 2 stage Drugs
Thalassemia Pipeline Phase 3 stage Drugs
Thalassemia Pipeline Pre Registration stage Drugs
3. Company wise Thalassemia Pipeline Compounds
4. Thalassemia Pipeline by Mechanism of Action
III. THALASSEMIA PIPELINE COMPOUND DETAILS
Drug Details
1. Snapshot
Name of the Therapeutic Agent
Originator
Developing Company
Co Developer/License Partner
Orphan Drug/Fast Track/Designation
Development Phase
2. Drug Overview
3. Mechanism of Action
4. Current Status
5. Clinical Trial Details
IV. THALASSEMIA PIPELINE COMPANY BRIEFS
V. LATEST NEWS AND DEVELOPMENTS IN GLOBAL THALASSEMIA PIPELINE MARKET
VI. APPENDIX
1. About Us
2. Research Methodology
3. Contact Information
The report will be delivered within 2 working days after procurement. Some of the sections depicted above may be modified in accordance with relevancy and availability
1. Companies Investing in Thalassemia Pipeline include
Number of Companies with Thalassemia projects in pre clinical Development
Number of Companies with Thalassemia projects in Clinical Development
Thalassemia Pipeline Companies based in Americas
Thalassemia Pipeline Companies based in Europe
Thalassemia Pipeline Companies based in Asia Pacific
Thalassemia Pipeline Companies based in Rest of the World
2. Pipeline Candidates include
Thalassemia Pipeline Agents in pre clinical/Discovery stage of Development
Thalassemia Pipeline Agents in Clinical Development stage
Thalassemia Pipeline Therapeutic Compounds received special status
Mechanism of Action of most pipeline Drugs
Small molecules among the Thalassemia Pipeline agents
II. INSIGHTS INTO THALASSEMIA PIPELINE
1. Disease Overview
Introduction to Thalassemia
Symptoms and Causes of Thalassemia
Treatment or Prevention Options for Thalassemia
Other Details
2. Phase wise Pipeline Compounds
Thalassemia Pipeline Pre Clinical/Discovery stage Drugs
Thalassemia Pipeline Phase 1 stage Drugs
Thalassemia Pipeline Phase 2 stage Drugs
Thalassemia Pipeline Phase 3 stage Drugs
Thalassemia Pipeline Pre Registration stage Drugs
3. Company wise Thalassemia Pipeline Compounds
4. Thalassemia Pipeline by Mechanism of Action
III. THALASSEMIA PIPELINE COMPOUND DETAILS
Drug Details
1. Snapshot
Name of the Therapeutic Agent
Originator
Developing Company
Co Developer/License Partner
Orphan Drug/Fast Track/Designation
Development Phase
2. Drug Overview
3. Mechanism of Action
4. Current Status
5. Clinical Trial Details
IV. THALASSEMIA PIPELINE COMPANY BRIEFS
V. LATEST NEWS AND DEVELOPMENTS IN GLOBAL THALASSEMIA PIPELINE MARKET
VI. APPENDIX
1. About Us
2. Research Methodology
3. Contact Information
The report will be delivered within 2 working days after procurement. Some of the sections depicted above may be modified in accordance with relevancy and availability
